Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
isoprenaline hydrochloride, Quantity: 1 mg
Medsurge Pharma Pty Ltd
Injection, solution
Excipient Ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid
Intracardial, Intramuscular, Intravenous Bolus, Intravenous Infusion, Subcutaneous
10 x 5 mL Ampoules
(S4) Prescription Only Medicine
Isoprenaline Hydrochloride is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,For serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation). (See Section 4.3 Contraindications),For use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (See Section 4.3 Contraindications.),For bronchospasm occurring during anaesthesia.,As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (See Section 4.4 Special warnings and precautions for use).
Visual Identification: Clear, colorless to slightly yellow colour solution. Practically free from any visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2022-02-10